# Graves’ Masquerade: A Case of Resistance to Thyroid Hormone (RTH) Syndrome

**Authors:** Yik Hin Chin, Dorothy Maria Anthony Bernard, Siew Hui Foo

PMC · DOI: 10.7759/cureus.78160 · Cureus · 2025-01-28

## TL;DR

A patient with RTH syndrome was misdiagnosed with Graves' disease for over eight years, highlighting the difficulty in distinguishing these conditions and the need for accurate diagnosis to avoid inappropriate treatment.

## Contribution

This case highlights the diagnostic challenge of RTH mimicking Graves' disease and emphasizes the importance of recognizing RTH to prevent inappropriate therapy.

## Key findings

- The patient presented with atrial fibrillation and was initially treated as having Graves' disease.
- Diagnosis of RTH was confirmed after more than eight years due to persistently elevated thyroid hormone and unsuppressed thyrotropin levels.
- The case underscores the need for careful evaluation to avoid suppressing compensatory thyroid hormone production in RTH patients.

## Abstract

Resistance to thyroid hormone (RTH) syndrome is characterized by reduced sensitivity to thyroid hormones (TH). It is an autosomal dominant genetic disease commonly caused by a mutation of the thyroid hormone receptor beta (THR-β) gene. Manifestations of RTH can be variable, as one can be clinically euthyroid to hyperthyroid or hypothyroid. We would like to share a case of resistance to thyroid hormone beta (RTH β) that presented with atrial fibrillation (AF) and was treated as Graves' disease with antithyroid drugs initially but was otherwise clinically euthyroid. The diagnosis was subsequently revised to RTH after a delay of more than eight years when the patient was referred to endocrinology for an aberrant thyroid function test with persistently raised TH and an unsuppressed thyrotropin level after performing the appropriate investigations. This case illustrates the challenge in diagnosing RTH in individuals with apparently preserved cardiac tissue TH sensitivity mimicking Graves' disease and the importance of recognition of RTH to avoid inappropriate therapy to suppress the compensatory increase in TH production to maintain the euthyroid state in affected individuals.

## Linked entities

- **Diseases:** Graves' disease (MONDO:0005364)

## Full-text entities

- **Genes:** THRB (thyroid hormone receptor beta) [NCBI Gene 7068] {aka C-ERBA-2, C-ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH}
- **Diseases:** RTH beta (MESH:D018382), aberrant thyroid function (MESH:D013966), AF (MESH:D001281), Graves' (MESH:D006111), hyperthyroid (MESH:D006980), hypothyroid (MESH:D007037), autosomal dominant genetic disease (MESH:D030342)
- **Chemicals:** thyrotropin (MESH:D013972)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11868728/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11868728/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC11868728/full.md

---
Source: https://tomesphere.com/paper/PMC11868728